rs1221804567
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_018972.4(GDAP1):c.503_504delAG(p.Glu168ValfsTer2) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018972.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth diseaseInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease axonal type 2KInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Charcot-Marie-Tooth disease recessive intermediate AInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- autosomal dominant Charcot-Marie-Tooth disease type 2KInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 4AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018972.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GDAP1 | NM_018972.4 | MANE Select | c.503_504delAG | p.Glu168ValfsTer2 | frameshift | Exon 4 of 6 | NP_061845.2 | ||
| GDAP1 | NM_001362930.2 | c.329_330delAG | p.Glu110ValfsTer2 | frameshift | Exon 3 of 5 | NP_001349859.1 | |||
| GDAP1 | NM_001040875.4 | c.299_300delAG | p.Glu100ValfsTer2 | frameshift | Exon 4 of 6 | NP_001035808.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GDAP1 | ENST00000220822.12 | TSL:1 MANE Select | c.503_504delAG | p.Glu168ValfsTer2 | frameshift | Exon 4 of 6 | ENSP00000220822.7 | ||
| GDAP1 | ENST00000434412.3 | TSL:1 | c.371_372delAG | p.Glu124ValfsTer2 | frameshift | Exon 5 of 7 | ENSP00000417006.3 | ||
| GDAP1 | ENST00000675463.1 | c.503_504delAG | p.Glu168ValfsTer2 | frameshift | Exon 4 of 7 | ENSP00000502327.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4A Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu168Valfs*2) in the GDAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GDAP1 are known to be pathogenic (PMID: 11743580). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GDAP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 467764). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at